HomeInsightsPE

Mangalam Drugs And Organics Ltd PE Ratio

Mangalam Drugs And Organics Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

4.3 K

stocks traded

Last Updated time: 19 Sep 9.00 AM

Image

Mangalam Drugs and Organics Ltd

NSE: MANGALAM

PE

0

Last updated: 19 Sep 9.00 AM

Key Highlights

  • The P/E Ratio of Mangalam Drugs and Organics Ltd is 0 as of 19 Sep 9.00 AM.
  • The P/E Ratio of Mangalam Drugs and Organics Ltd changed from 5.8 on March 2019 to 122.3 on March 2023 . This represents a CAGR of 114.29% over 4 years. .
  • The Latest Trading Price of Mangalam Drugs and Organics Ltd is ₹ 127.15 as of 19 Sep 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.2. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.8. In 2024.

Historical P/E Ratio of Mangalam Drugs and Organics Ltd

No data available

Company Fundamentals for Mangalam Drugs and Organics Ltd

No data available

Image

Mangalam Drugs and Organics Ltd

NSE: MANGALAM

PRICE

127.15

-8.15 (-6.02%)

stock direction

Last updated: 19 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Mangalam Drugs and Organics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 2024127.15
18 Sep 2024135.3
17 Sep 2024138.15
16 Sep 2024135.85
13 Sep 2024134.8
12 Sep 2024128.65
11 Sep 2024130.25
10 Sep 2024131.45
09 Sep 2024130.9
06 Sep 2024131.35

SWOT Analysis Of Mangalam Drugs and Organics Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Mangalam Drugs and Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Mangalam Drugs and Organics Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Mangalam Drugs and Organics Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical Revenue of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical EBITDA of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical Net Profit of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical Dividend Payout of Mangalam Drugs and Organics Ltd

No data available

* All values are in %

About Mangalam Drugs and Organics Ltd

  • Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001.
  • The company was promoted by Dhoot family.
  • The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals.
  • The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates.
  • The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra.

Mangalam Drugs and Organics Ltd News Hub

News

Mangalam Drugs and Organics to declare Quarterly Result

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

10 Aug 202413:02

News

Mangalam Drugs and Organics declare Quarterly Result

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

15 May 202416:29

News

Mangalam Drugs and Organics to conduct board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

08 Mar 202417:35

News

Mangalam Drugs and Organics announces board meeting date

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

08 Feb 202413:47

News

Mangalam Drugs and Organics to discuss results

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

02 Nov 202314:04

News

Mangalam Drugs and Organics to conduct board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

07 Aug 202315:03

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Mangalam Drugs and Organics Ltd

What is the current PE Ratio of Mangalam Drugs and Organics Ltd?

The Current PE Ratio of Mangalam Drugs and Organics Ltd is 0.0 as on 19 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.2 as on 19 Sep 2024.

What was the PE Ratio of Mangalam Drugs and Organics Ltd last year?

The PE Ratio of Mangalam Drugs and Organics Ltd was 8.28 last year, now the PE ratio is 0.0, showing a year-on-year growth of -100.0%.

What does the PE Ratio of Mangalam Drugs and Organics Ltd indicate about its stock?

The PE Ratio of Mangalam Drugs and Organics Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Mangalam Drugs and Organics Ltd.

What is the PE Ratio Growth of Mangalam Drugs and Organics Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Mangalam Drugs and Organics Ltd grew by -100.0% whereas, the EPS ratio grew by -23.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*